These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8609074)

  • 1. BE-29602, a new member of the Papulacandin family.
    Okada H; Nagashima M; Suzuki H; Nakajima S; Kojiri K; Suda H
    J Antibiot (Tokyo); 1996 Jan; 49(1):103-6. PubMed ID: 8609074
    [No Abstract]   [Full Text] [Related]  

  • 2. Mer-WF3010, a new member of the papulacandin family. I. Fermentation, isolation and characterization.
    Kaneto R; Chiba H; Agematu H; Shibamoto N; Yoshioka T; Nishida H; Okamoto R
    J Antibiot (Tokyo); 1993 Feb; 46(2):247-50. PubMed ID: 8468238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaetiacandin, a novel papulacandin. I. Fermentation, isolation and characterization.
    Komori T; Yamashita M; Tsurumi Y; Kohsaka M
    J Antibiot (Tokyo); 1985 Apr; 38(4):455-9. PubMed ID: 3839230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusacandins A and B; novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum. I. Identity of the producing organism, fermentation and biological activity.
    Jackson M; Frost DJ; Karwowski JP; Humphrey PE; Dahod SK; Choi WS; Brandt K; Malmberg LH; Rasmussen RR; Scherr MH
    J Antibiot (Tokyo); 1995 Jul; 48(7):608-13. PubMed ID: 7649856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of saricandin, a novel papulacandin, from a Fusarium species.
    Chen RH; Tennant S; Frost D; O'Beirne MJ; Karwowski JP; Humphrey PE; Malmberg LH; Choi W; Brandt KD; West P; Kadam SK; Clement JJ; McAlpine JB
    J Antibiot (Tokyo); 1996 Jun; 49(6):596-8. PubMed ID: 8698645
    [No Abstract]   [Full Text] [Related]  

  • 6. Mer-WF3010, a new member of the papulacandin family. II. Structure determination.
    Chiba H; Kaneto R; Agematu H; Shibamoto N; Yoshioka T; Nishida H; Okamoto R
    J Antibiot (Tokyo); 1993 Feb; 46(2):356-8. PubMed ID: 8468253
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel bioactive constituents from Enhydra fluctuans LOUR.
    Yadava RN; Singh SK
    Nat Prod Res; 2007 May; 21(6):481-6. PubMed ID: 17497419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathemycin A, a new antifungal macrolactone from Actinomycete sp. HIL Y-8620959. I. Fermentation, isolation, physico-chemical properties and biological activities.
    Nadkarni SR; Mukhopadhyay T; Bhat RG; Gupte SV; Sachse B
    J Antibiot (Tokyo); 1998 Jun; 51(6):579-81. PubMed ID: 9711221
    [No Abstract]   [Full Text] [Related]  

  • 9. Validamycin H, a new pseudo-tetrasaccharide antibiotic.
    Asano N; Kameda Y; Matsui K; Horii S; Fukase H
    J Antibiot (Tokyo); 1990 Aug; 43(8):1039-41. PubMed ID: 2211355
    [No Abstract]   [Full Text] [Related]  

  • 10. A new antifungal antibiotic, 3'-O-decarbamoylirumamycin.
    Nakagawa A; Tanaka Y; Otoguro K; Omura S; Takiguchi T; Arai Y
    J Antibiot (Tokyo); 1985 Sep; 38(9):1266-9. PubMed ID: 4066506
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumocandin D0, a new antifungal agent and potent inhibitor of Pneumocystis carinii.
    Morris SA; Schwartz RE; Sesin DF; Masurekar P; Hallada TC; Schmatz DM; Bartizal K; Hensens OD; Zink DL
    J Antibiot (Tokyo); 1994 Jul; 47(7):755-64. PubMed ID: 8071120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH57404, an antifungal agent possessing the rare sodaricin skeleton and a tricyclic sugar moiety.
    Coval SJ; Puar MS; Phife DW; Terracciano JS; Patel M
    J Antibiot (Tokyo); 1995 Oct; 48(10):1171-2. PubMed ID: 7490228
    [No Abstract]   [Full Text] [Related]  

  • 13. Norlanostane triterpenoidal saponins from the marine sponge melophlussarassinorum.
    Dai HF; Edrada RA; Ebel R; Nimtz M; Wray V; Proksch P
    J Nat Prod; 2005 Aug; 68(8):1231-7. PubMed ID: 16124767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sharpless asymmetric dihydroxylation of 5-aryl-2-vinylfurans: application to the synthesis of the spiroketal moiety of papulacandin D.
    Balachari D; O'Doherty GA
    Org Lett; 2000 Mar; 2(6):863-6. PubMed ID: 10754689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RK-397, a new oxo pentaene antibiotic.
    Kobinata K; Koshino H; Kudo T; Isono K; Osada H
    J Antibiot (Tokyo); 1993 Oct; 46(10):1616-8. PubMed ID: 8244892
    [No Abstract]   [Full Text] [Related]  

  • 16. New 3-O-Alkyl-4a,10a-dihydrofusarubins produced by Fusarium sp. Mj-2.
    Suzuki M; Nishida N; Ishihara A; Nakajima H
    Biosci Biotechnol Biochem; 2013; 77(2):271-5. PubMed ID: 23391915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteridinines A and B from slime mold Enteridium lycoperdon.
    Rezanka T; Dvoráková R; Hanus LO; Dembitsky VM
    Phytochemistry; 2004 Feb; 65(4):455-62. PubMed ID: 14759541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papulacandins, a new family of antibiotics with antifungal activity. Structures of papulacandins A, B, C and D.
    Traxler P; Fritz H; Fuhrer H; Richter WJ
    J Antibiot (Tokyo); 1980 Sep; 33(9):967-78. PubMed ID: 7440418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaetiacandin, a novel papulacandin. II. Structure determination.
    Komori T; Itoh Y
    J Antibiot (Tokyo); 1985 Apr; 38(4):544-6. PubMed ID: 3839234
    [No Abstract]   [Full Text] [Related]  

  • 20. New cyclic depsipeptide antibiotics, clavariopsins A and B, produced by an aquatic hyphomycetes, Clavariopsis aquatica. 1. Taxonomy, fermentation, isolation, and biological properties.
    Kaida K; Fudou R; Kameyama T; Tubaki K; Suzuki Y; Ojika M; Sakagami Y
    J Antibiot (Tokyo); 2001 Jan; 54(1):17-21. PubMed ID: 11269710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.